Improving Treatment Adherence Through a CML Specialty Pharmacy Service Model
A two-way clinical messaging platform in a specialty pharmacy service model may positively affect adherence outcomes in patients with chronic myeloid leukemia.
CMS Proposes Expanded Coverage of NGS Testing in Ovarian, Breast Cancer
The Centers for Medicare & Medicaid Services is proposing expanding coverage of next-generation sequencing testing for patients with ovarian and breast cancer.
Quantifying the Economic Impact of Drug Wastage in Metastatic Breast Cancer
Drug wastage costs associated with palbociclib for treating patients with advanced or metastatic breast cancer may be substantial.
Oncology Care Standardization System Reduces Variation in Clinically Integrated Network
A recent project sought to engage breast and lung cancer oncologists across a clinically integrated network in the care standardization process to improve evidence-based and cost-effective care.
ASCO Patient-Centered Oncology Payment Model Cost-Savings in Patients With Ovarian Cancer
A care delivery study evaluated the American Society of Clinical Oncology Patient-Centered Oncology Payment model for potential cost savings in Medicare beneficiaries with newly diagnosed, advanced ovarian cancer.
Maintenance Regimen With PARP Inhibitor Shows Survival Benefit in Ovarian Cancer
Combining the poly ADP ribose polymerase inhibitor olaparib with bevacizumab in the maintenance setting for advanced ovarian cancer extends progression-free survival, according to recent research.
